基于前列腺癌免疫治疗的策略:一篇更新的评论强调免疫检查点抑制剂
Hua Lu1, Zhaojun Teng1, Jiajia Wang2
1Department of Urology, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, China.
Frontiers in immunology
|July 3, 2025
概括
前列腺癌 (PC) 治疗经常失败,导致复发. 免疫疗法,特别是免疫检查点抑制剂 (ICI),显示出改善前列腺癌护理结果的希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 前列腺癌 (PC) 是癌症相关死亡的主要原因,目前的化学疗法和雄激素剥夺疗法 (ADT) 等治疗方法具有很高的复发率.
- 传统疗法的局限性需要探索晚期前列腺癌的新型治疗策略.
研究的目的:
- 审查标准前列腺癌治疗的疗效和风险因素.
- 探索各种免疫疗法的潜力,重点是免疫检查点抑制剂 (ICI),用于前列腺癌治疗.
主要方法:
- 对前列腺癌治疗疗效和风险因素的当前文献的综述.
- 详细讨论不同的免疫疗法类型,包括细胞因子,细胞疗法和基于抗体的方法.
- 强调免疫检查点抑制剂 (ICI) 和它们在前列腺癌中的应用.
主要成果:
- 前列腺癌的标准治疗方法长期有效性有限,并且与显著的复发率有关.
- 免疫疗法,特别是ICI,由于前列腺癌细胞上免疫检查点 (ICP) 分子的高表达,显示出有希望的结果.
- 涉及ICI与化疗,手术或放射治疗的组合疗法可能会提高治疗效率.
结论:
- 前列腺癌治疗正在发展,免疫疗法成为重点关注的关键领域.
- 免疫检查点抑制剂 (ICI) 是前列腺癌的有希望的治疗途径,有可能改善患者的治疗结果.
- 对组合策略的进一步研究是有必要的,以最大限度地发挥ICI在治疗前列腺癌的好处.
更多相关视频
09:04Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
705
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.0K
相关概念视频
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
Cancer Vaccines
517
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
517
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
